CITIGROUP INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,671,438
-9.2%
69,025
+16.4%
0.01%0.0%
Q2 2023$12,856,603
+111.9%
59,288
+77.5%
0.01%
+125.0%
Q1 2023$6,068,230
+57.1%
33,408
+69.9%
0.00%
+33.3%
Q4 2022$3,862,797
-36.8%
19,658
-27.6%
0.00%
-25.0%
Q3 2022$6,110,000
+20.3%
27,163
-32.3%
0.00%0.0%
Q2 2022$5,079,000
+288.6%
40,149
+289.4%
0.00%
+300.0%
Q1 2022$1,307,000
-86.1%
10,310
-85.7%
0.00%
-80.0%
Q4 2021$9,416,000
+245.7%
71,883
+222.8%
0.01%
+150.0%
Q3 2021$2,724,000
-30.7%
22,268
-35.4%
0.00%0.0%
Q2 2021$3,930,000
-14.1%
34,480
-9.4%
0.00%
-33.3%
Q1 2021$4,573,000
+361.0%
38,037
+289.4%
0.00%
+200.0%
Q4 2020$992,000
+51.9%
9,767
+15.7%
0.00%
Q3 2020$653,000
-72.4%
8,439
-60.3%
0.00%
-100.0%
Q2 2020$2,369,000
+210.5%
21,254
+100.6%
0.00%
+100.0%
Q1 2020$763,000
+130.5%
10,597
+141.7%
0.00%
Q4 2019$331,000
+10933.3%
4,385
+2060.1%
0.00%
Q3 2019$3,000
-98.7%
203
-98.2%
0.00%
Q2 2019$230,00011,5000.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders